Literature DB >> 18262856

Is newborn screening for cystic fibrosis a basic human right?

Philip M Farrell1.   

Abstract

Because it is clearly in the best interests of children with cystic fibrosis to be diagnosed early at <2 months, which can only be achieved routinely by newborn screening, it can be argued that this should be a human right. However, if more harm than good is likely, or if regional "readiness" does not exist, newborn screening should be deferred.

Entities:  

Mesh:

Year:  2008        PMID: 18262856      PMCID: PMC2504861          DOI: 10.1016/j.jcf.2008.01.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  22 in total

1.  Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

Authors:  Don S Lee; Marjorie A Rosenberg; Andrew Peterson; Linda Makholm; Gary Hoffman; Ronald H Laessig; Philip M Farrell
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

2.  The meaning of "early" diagnosis in a new era of cystic fibrosis care.

Authors:  Philip M Farrell
Journal:  Pediatrics       Date:  2007-01       Impact factor: 7.124

3.  Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.

Authors:  Erika J Sims; Allan Clark; Jonathan McCormick; Gita Mehta; Gary Connett; Anil Mehta
Journal:  Pediatrics       Date:  2007-01       Impact factor: 7.124

4.  Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.

Authors:  Anne Marie Comeau; Frank J Accurso; Terry B White; Preston W Campbell; Gary Hoffman; Richard B Parad; Benjamin S Wilfond; Margaret Rosenfeld; Marci K Sontag; John Massie; Philip M Farrell; Brian P O'Sullivan
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

Review 5.  Overview of published evidence on outcomes with early diagnosis from large US observational studies.

Authors:  Margaret Rosenfeld
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

6.  Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).

Authors:  D Siret; G Bretaudeau; B Branger; A Dabadie; M Dagorne; V David; M de Braekeleer; V Moisan-Petit; G Picherot; G Rault; V Storni; M Roussey
Journal:  Pediatr Pulmonol       Date:  2003-05

Review 7.  Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis.

Authors:  Scott D Grosse; Margaret Rosenfeld; Owen J Devine; Huichuan J Lai; Philip M Farrell
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

8.  Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs.

Authors:  P Farrell; S Joffe; L Foley; G J Canny; P Mayne; M Rosenberg
Journal:  Ir Med J       Date:  2007-09

9.  Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

Authors:  Philip M Farrell; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Hui-Chuan Lai; Linda M Makholm; Michael J Rock; Mark L Splaingard
Journal:  Pediatr Pulmonol       Date:  2003-09

10.  Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

Authors:  Rebecca L Koscik; Philip M Farrell; Michael R Kosorok; Kathleen M Zaremba; Anita Laxova; Hui-Chuan Lai; Jeff A Douglas; Michael J Rock; Mark L Splaingard
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

View more
  1 in total

1.  Newborn Screening for Cystic Fibrosis: Over the Hump, Still Need to Fine-Tune It.

Authors:  Carlo Castellani
Journal:  Int J Neonatal Screen       Date:  2020-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.